DAR boosted anti‐D HDFN in a Caucasian family

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Transfusion Medicine

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tme.12176PMID 25720578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti‐D prophylaxis: past, present and future

  2014cited by this paper
• Variants of RhD – current testing and clinical consequences

  2013influential reference
• Rh and RHAG Blood Group Systems

  2013influential reference
• Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratories

  2013cited by this paper
• Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA

  2013cited by this paper
• The Rh and RhAG blood group systems

  2010cited by this paper
• Guideline for blood grouping and antibody testing in pregnancy

  2007influential reference
• High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD

  2005cited by this paper
• Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

  2002cited by this paper
• RhD haemolytic disease of the fetus and the newborn.

  2000cited by this paper
• DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks.

  1999influential reference
• Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratories

  1996cited by this paper

• No citing papers are available for this paper.